- Location
Biopharmaceutical development
"-
The FDA Has Approved Breakthrough Therapy Designation for Genmab and Arzerra
Sep 17, 2013The US Food and Drug Administration (FDA) has approved breakthrough therapy designation for Danish biotechnology company Genmab and British pharmaceutical company GlaxoSmithKline’s (GSK) Arzerra (ofatumumab) in combination with ...
Tags: therapy designation, Medicine
-
Chelsea Therapeutics Has Announced The Us FDA Acceptance of Northera NDA Resubmission
Jul 22, 2013Biopharmaceutical development company Chelsea Therapeutics has announced the US FDA acceptance of Northera (droxidopa) new drug application (NDA) resubmission to treat symptomatic neurogenic orthostatic hypotension (NOH). The company is ...
-
A Provider of Biopharmaceutical Development and Manufacturing Services
Apr 5, 2013Ajinomoto has completed the acquisition of Althea Technologies, a provider of biopharmaceutical development and manufacturing services. All the capital stock of Althea is purchased by Ajinomoto at closing for approximately $175m. Althea ...
Tags: Ajinomoto, Althea Technologies, Medicine
